BSE filing, NSE: RNBDENIMS. Summary written from the filing by ALFA Finder's alert engine.
R&B Denims Ltd: key numbers
- Share price
- ₹7.98
- Market cap
- ₹215.4 Cr
- Revenue (annual)
- ₹465.9 Cr
- Net profit (annual)
- ₹16.96 Cr
- P/E (TTM)
- 10.3×Sector 49.0×
- Promoter holding
- 57.39%+0.00% QoQ
- FII holding
- 4.27%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from R&B Denims Ltd
All →R&B Denims Board Meeting Date
R&B Denims will hold a board meeting on November 5, 2026. The board will consider standalone and consolidated unaudited results for the quarter and half year ended September 30, 2026.
R&B Denims Management Change
R&B Denims' Company Secretary and Compliance Officer, Sujata Chirag Dudharejiya, resigned effective October 31, 2026, citing health reasons. The company also listed its current KMP contacts.
R&B Denims Debt & Borrowing: ₹1.5 Cr
R&B Denims approved a Rs 1.5 Crore unsecured loan to Shilpa Dyeing at 13.80% interest. The loan carries no security and no related-party link.
- Value
- ₹1.50 Cr
R&B Denims Acquisition Worth ₹5.51 Cr
R&B Denims bought 0.13% of Beroe Consulting India for ₹5.51 Crore via a Deed of Adherence. The minority stake, funded from surplus cash, carries no special rights.
- Value
- ₹5.51 Cr
R&B Denims ED Probe / Tax Survey
R & B Denims Ltd announced a search proceeding initiated by the Enforcement Directorate at its registered office and promoter premises. No material impact is reported currently.
R&B Denims Other Announcement
R&B Denims Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, pursuant to SEBI Regulation 31.
Other bonus issue announcements
All →Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels' board recommended a 1:1 bonus issue from free reserves on 23 October 2026. Paid-up capital rises from Rs.25.00 Crore to Rs.50.00 Crore, subject to AGM/postal ballot on 25 November 2026.